Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection
Nicolas Venisse, Gilles Peytavin, Stéphane Bouchet, Marie‐Claude Gagnieu, R. Garraffo, Romain Guilhaumou, Caroline Solas
Topics & Concepts
PharmacokineticsMedicineDosingContext (archaeology)Coronavirus disease 2019 (COVID-19)PharmacodynamicsPharmacologyIntensive care medicinePandemicPopulationClinical trialDiseaseInternal medicineInfectious disease (medical specialty)BiologyPaleontologyEnvironmental healthAntibiotics Pharmacokinetics and EfficacyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research